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Abstract:

The goal of this study was to determine whether actinomycetes isolated from a volcanic
cave in western Canada could produce novel antimicrobial compounds against six multidrugresistant pathogens when exposed to UV light. One hundred and seventy-six actinomycete
strains isolated from Helmcken Falls Cave, Wells Gray Provincial Park, BC, were screened
against six pathogens using the “plug assay” in UV light and no light conditions. Of the 176
strains tested, 100 or 57% of the cave actinomycete strains had antimicrobial activities
against the pathogens in 124 different instances: 35 instances when exposed to UV and
no light, 30 when exposed to UV light, and 59 instances when exposed to no light. The
metabolites of six actinomycete strains also lost their antimicrobial activities when exposed
to UV light. While the metabolites produced by these strains have yet to be determined,
exposure to lighted environments may either deactivate or enhance the antimicrobial activities
of cave actinomycete strains. This study represents a confirmation that cave actinomycetes
are potential sources of novel antimicrobial compounds and also is the first report of the
enhancement of antimicrobial activities of some cave bacteria by exposure to UV light. Further
investigation of the role of UV light with respect to activation/deactivation of antimicrobial
activities of cave actinomycetes is required.
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INTRODUCTION
Antibiotic resistance continues to pose a significant
threat to the clinical and pharmaceutical world. Many
common hospital pathogens are becoming multi-drug
resistant and are unable to be treated with many -if
any- of the commercially available antibiotics (Davies
& Davies, 2010). Multi-drug resistant microorganisms
are a significant problem as they are a leading cause
of human death worldwide (Selvameenal et al., 2009)
and antibiotics are still currently the only effective way
to treat infectious microbial diseases. Thus, the need
for novel antimicrobial compounds is greater now than
ever before. Fortunately, filamentous, Gram-positive
bacteria known as the actinomycetes-particularly
the Streptomyces species- produce antimicrobials
in nature and have been the largest source of new
antibiotic drug candidates and leading molecules
to date (Genilloud et al., 2011). Out of the 22,500
secondary metabolites with antimicrobial activities
that have been found in studies, 10,100 (or 45%)
have been produced by actinomycetes (Selvameenal
*ncheeptham@tru.ca

et al., 2009). In particular, actinomycetes from
less-explored habitats show exceptional promise to
produce novel antimicrobial compounds (Genilloud et
al., 2011). This was already anticipated by Groth et
al. (1999) in a study on the Spanish caves of Altamira
and Tito Bustillo. For instance, a new antimicrobialproducing
actinomycete
strain,
Streptomyces
tendae HKI 0179, was isolated from the ancient
cave Grotta dei Cervi in Italy by Groth et al. (2001).
Streptomyces tendae HKI 0179 produced novel forms
of antimicrobials called cervimycins (Herold et al.,
2005) which showed high levels of antimicrobial
activities against the pathogens Bacillus subtilis,
multi-drug resistant Staphylococcus aureus (MRSA),
and vancomycin-resistant Enterococcus faecalis (VRE)
1528. These antimicrobials were as effective as those
such as vancomycin, tetracycline, and ciprofloxacin
that are currently used to treat infections caused
by these organisms. A recent study by Rajput et
al. also discovered several Streptomyces strains
(Streptomyces prasinosporus KCA strains 3, 8, and
22, Streptomyces aurantiacus KCA6, Streptomyces
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roseus KCA13, Streptomyces longiosporoflavus
KCA18, and Streptomyces luridus KCA23) isolated
from the Kotsumar Cave in India that produced
significant antimicrobial activities against the three
drug-resistant human pathogens Pseudomonas
aeruginosa, Escherichia coli, and Staphylococcus
aureus (Rajput et al., 2012). Overall, these studies
show that natural antimicrobial compounds produced
by cave actinomycetes are strong contenders for the
new antimicrobials that are needed to ease the multidrug resistance problem.
Previous studies have shown an increasing number
of fungal and plant natural products that have lightmediated activities against fungi, insects, bacteria,
viruses, and cells (Towers et al., 1997). A study carried
out by Hudson and colleagues in 2000, for example,
tested the antiviral activities of seven species of African
medicinal plant extracts that were exposed to longwave UV light (UVA, which has a wavelength of 315400 nm) and fluorescent light (visible light, which has
a wavelength of 185-254 nm) against the type 1 herpes
simplex virus (Hudson et al., 2000). The plant extracts
showed the most antiviral activities against the virus
when the extracts were exposed to light, particularly
UVA light. Similarly, Cheeptham and Towers studied
the light-mediated activities of a wide variety of Thai
medicinal plant tea extracts in 2002 (Cheeptham &
Towers, 2002). They too demonstrated the remarkable
ability of plant extracts to produce antimicrobial and
antifungal compounds against an array of bacterial
and fungal pathogens when subjected to UV light
(from 5 W/m2, 320-400 nm Sylvanian F20T12-BLB
lamps). Thus, investigation as to whether UV light
can stimulate the metabolites of cave actinomycetes
to produce antimicrobial activities for a potentially
wider and more specific therapeutic use would be of
great benefit.

MATERIALS AND METHODS
Organisms and growth conditions
Growth of the cave actinomycete strains
One hundred and seventy-six cave actinomycete
strains of over 400 strains previously isolated from
Wells Gray Provincial Park in Clearwater, BC, Canada
were primarily subcultured onto 25-30 mL Hickey
Tresner (HT) agar plates (10 g/L dextrin, 1 g/L yeast
extract, 1 g/L beef extract, 2 g/L N-Z Amine Type
A, 15 g/L agar, pH 7.3) using the confluent-streak
technique. The plates were incubated at 25°C for 7
to 10 days. For the strains that did not grow well,
a “plug” of each strain was transferred -using the
open end of a 20-200 µL pipette tip (sterile)- from its
original stock plate to a fermentation tube (13x100
mm size) with six mL of HT broth. The tubes were
then placed in a 25°C shaker for approximately 7
to 10 days to obtain uniform growth. Each of the
isolates was confluent-streaked onto HT agar plates
using sterile polyester tipped applicators (swabs) and
was then incubated at 25oC for 7 to 10 days. These
plates were then used as the origin of the plugs for
the bioassay.

Growth of the pathogens
The six pathogen strains used in this project include:
Mycobacterium smegmatis strain JVC1213 (MC2155),
Extended Spectrum β-Lactamase (ESBL)-producing
Escherichia coli strain 1841 JVC1195, Micrococcus
luteus, Multi-Drug Resistant Staphylococcus aureus,
Acinetobacter baumannii strain 14394, and Candida
albicans (Table 1). The pathogens were provided
by Dr. Julian Davies from the University of British
Columbia (UBC), in Vancouver, BC and Dr. Gwen
Stephens from the Department of Pathology at the
Royal Inland Hospital (RIH), in Kamloops, BC.
To culture the pathogens, a loopful or bead (if taken
from the -80oC freezer) of each pathogen was placed
into 40 mL of liquid broth medium that is known to
encourage the growth of each strain (Table 1). The
flask was then incubated at either 35°C or 25°C (for
Candida albicans) on an orbital shaker at 200 rpm.
Optical density readings of each pathogen at 600 nm
wavelength were recorded and matched with the 0.5
McFarland standard for logarithmic growth. 0.5% of
each pathogen was then transferred to the molten
agar prepared for the bioassay as described below.
Conventional Agar Plug Assay
To screen for antimicrobial activity of the
metabolites of the cave actinomycetes against the six
multi-drug resistant pathogens, a series of seeded
bioassay plates were prepared using the conventional
agar plug assay (Murakami et al., 1986) also known
as the agar plug method. Each of the six pathogens
was grown separately in liquid medium as described
above. Then, 0.5% (v/v) (1.25 mL) of each pathogen at
log phase was added to two 250 mL flasks of molten
nutrient agar (potato-dextrose-agar in the case of
Candida albicans) which were kept warm in a 55°C
water bath. The agar was then poured into two 25
by 25 mm square bioassay plates. After solidification,
agar plugs of the cave actinomycete strains (these cave
actinomycetes had already been cultured for 7 to 10
days prior to this step to ensure secondary metabolite
production) were transferred onto each of the two
identical bioassay plates in the same pattern using
the open ends of sterile 20-200 µL pipette tips (Fig. 1).
A disk impregnated with sterile water was also added
to each of the plates as a negative control, while a disk
Table 1. Six antimicrobial-resistant pathogens used in this study.
Medium
Used

Gram
Reaction

OD600
Values
at Log
Phase

Approximate
Time Required
to Reach Log
Phase (hrs)

N.E.

+

0.7

82

L.B.

-

0.6

6

Micrococcus luteus

N.B.

+

0.6

12

MDR-S. aureus

L.B.

+

0.5

5

Acinetobacter
baumannii
strain 14394

N.B.

-

0.6

12

Candida albicans

Y.M.

mold (yeast)

0.7

24

Drug- Resistant
Pathogen
Mycobacterium
smegmatis strain
JVC1213 (MC2155)
ESBL-producing
Escherichia coli strain
1841 JVC1195

The medium that each pathogen was grown in, the pathogen’s Gram
reaction and optical density value (OD600) at log phase, and the
approximate amount of time required to reach the pathogen’s log
phase (hrs) is also given.
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soaked with 3 or 5 mg of 8-methoxypsoralen (8-MOP;
a common substance that is light-reactive and can
be used to show antimicrobial activity) in one mL of
methanol was added to each plate as a UV indicator
(or light-activated activity positive control).
Subsequently, one of the assay plates was subjected
to one hour of UV light (254 nm) in the Labconco Flow
Hood with its lid open, while the other plate received
no UV light treatment and sat in the dark lab for an
hour. Afterwards, the lid was placed back on the UV
light plate and both the UV and no light plate were
incubated overnight at 35°C (25° for C. albicans) in
the dark lab. Any inhibitory zones and their diameters
were measured and recorded after the incubation
period. The positive controls for antimicrobial activity
used in this study varied depending on the pathogens
used in the assay plates (Table 2).

RESULTS
Of the 176 strains tested, the metabolites of
57% or 100 of the cave actinomycete strains had
antimicrobial activities against the six pathogens
tested in 124 different instances. In 35 instances the
metabolites had antimicrobial activities in both UV
and no light, in 30 instances they had antimicrobial
activities in UV light, and in the remaining 59
instances they had antimicrobial activities in no light
(Fig. 2, Table 3).
Notably, no single cave actinomycete isolate produced
metabolites with antimicrobial activities against
all six of the pathogens. Strain E9’s metabolites,
however, produced antimicrobial activities against all
of the pathogens except for Candida albicans (Table
4). The metabolites of cave actinomycete strain 100
showed the greatest antimicrobial activities of all of
the metabolites, producing a zone of inhibition 27
mm in diameter against Candida albicans in UV light
conditions (Table 4). Conversely, E25’s metabolites
showed the least antimicrobial activities of all of the

Pathogen

Antibiotic Disk Used as a Positive Control

Mycobacterium smegmatis JVC 1213
(MC2155)

SXT (sulfamethoxazole- 23.75 µg, and
trimethoprim- 1.25 µg)

ESBL-producing Escherichia coli
strain 1841 JVC1195

CFP (cefoperazone- 75 µg)

Micrococcus luteus

TET (tetracycline- 30 µg)

MDR-S.aureus

TET (tetracycline- 30 µg)

Acinetobacter baumannii strain 14394

CAZ (ceftazidime -30 µg)

Candida albicans

N/A – antifungal (nystatin- 20 µg)

Table 3. The number of cave actinomycete strains’ metabolites that
had antimicrobial activities against the six drug-resistant pathogens in
different conditions.
Conditions
Pathogen

UV light

Non-UV

Both

Total

M. luteus

2

7

4

13

MDR-S. aureus

1

2

1

4

M. smegmatis

11

28

10

49

ESBL- producing- E. coli

0

3

0

3

A. baumannii

0

6

3

9

C. albicans

16

13

17

46

Total

30

59

35

124

The pathogens that were most susceptible to the metabolites of the
cave actinomycetes are shaded. The total number of metabolites
that had antimicrobial activities against the pathogens in each of the
different conditions is also given.

metabolites, producing not much more than a six mm
zone of inhibition against ESBL-producing Escherichia
coli in no light conditions. Also, it seems that
Mycobacterium smegmatis and Candida albicans were
the most susceptible pathogens to the antimicrobial
activities of the cave actinomycetes’ metabolites in
this study. The metabolites of 49 cave actinomycete
strains produced antimicrobial activities against
Mycobacterium smegmatis, while the metabolites of
46 strains produced antimicrobial activities against
Candida albicans (Table 4). The metabolites of six
cave actinomycete strains lost their antimicrobial
activities when they were exposed to one hour of UV
light, as well (Table 5). The identification of the six
cave actinomycetes by 16S rRNA sequencing is shown
in Table 6.

Number of actinomycete strains'
metabolites activated

30

The number of cave actinomycete strains' metabolites that
were activated against the drug-resistant pathogens in
different conditions

25

UV light

20

No UV
Both

15
10
5
0

Fig. 1. An example of a seeded plate prepared using the “plug assay”
to assess the antimicrobial activities of the cave actinomycete strains’
metabolites against the antimicrobial-resistant pathogen Micrococcus
luteus when the metabolites were exposed to UV light. The diameters
of the dark, inhibitory zones that encircle the actinomycete plugs were
measured to assess the antimicrobial activities of the metabolites.
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Table 2. Positive controls against the six antimicrobial-resistant
pathogens used in this study.

M. luteus

MDR- S.
aureus

M. smegmatis ESBL-E. coli A. baumannii C. albicans

Pathogen

Fig. 2. The number of cave actinomycete strains’ metabolites that had
antimicrobial activities against the six drug-resistant pathogens in UV
light, no light, and both UV light and no light conditions.
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Table 4. The antimicrobial activities of the metabolites of cave
actinomycete strains E9, PM100 and E25 against the six
antimicrobial-resistant pathogens used in this project. The diameters
of the zones of inhibition produced by the metabolites are given in
millimetres (mm). The shaded boxes highlight the metabolites that
had antimicrobial activities in UV light conditions.
Pathogen
Actinomycete
strain

M.
luteus

MDRS.aureus

M.
smegmatis

ESBL
E. coli

A.
baumannii

C.
albicans

E9

16

13

20

7

13

0

E9

12

9.5

0

0

0

0

100

0

0

9

0

0

27

E25

12

13.5

0

6

0

0

E25

11

0

0

0

0

0

DISCUSSION
Based on the results observed from the agar plug
assay tested in our study, cave actinomycetes have the
potential to produce antimicrobial compounds that
are needed to help combat the antibiotic resistance
phenomenon. In particular, the antimicrobial
compounds produced by strain E9 in our study
were effective against many different pathogens and
may have the potential to be developed into broadspectrum antibiotics in the future. However, the
chemical composition and modes of action of the
antimicrobials produced in our study have yet to be
determined by isolating the metabolites with highperformance liquid chromatography and examining
their structures with mass spectrometry and nuclear
magnetic resonance spectroscopy, as suggested by a
previous study (Herold et al., 2005). The media used
for antimicrobial production in the current study also
need to be optimized in order to obtain the highest
yield of metabolites as possible (only HT agar was
Table 5. The metabolites of six cave actinomycete strains that lost their
antimicrobial activities under UV light exposure. The diameters of the
zones of inhibition produced by the metabolites on the seeded plates are
given in millimetres (mm). Shaded bars represent non-UV light conditions
while the white bars represent UV light conditions. The outlined boxes
highlight the instances where the metabolites of the cave actinomycete
strains lost their antimicrobial activities in UV light conditions.
Pathogen
Actinomycete
Strain

M.
luteus

MDRS.aureus

M.
smegmatis

ESBLE.coli

A.
baumannii

C.
albicans

0

0

19

0

19

10

-

-

17

-

17

-

NC-18

15

7

0

0

12

0

NC-18

12

-

-

-

-

0

NC-39

8

0

13

0

0

10

PM 106
(DR031)
PM 106
(DR031)

NC-39

-

-

19

-

-

26.5

E9

16

13

20

7

13

0

E9

12

9.5

-

-

-

0

E25

12

13.5

0

6

0

0

E25

11

-

-

-

-

0

unknown 9

11

0

8

0

0

0

unknown 9

11

-

-

-

-

0

Table 6. Identification of some cave actinomycetes by 16S rRNA
sequencing (Cheeptham et al., 2013).
Actinomycete
strain

Species (Identified by 16S rRNA
sequencing)

% similarity

Accession #

PM 106

Streptomyces microflavus

99

JQ422124

NC-18

Streptomyces coelescens

99

JQ422176

NC-39

Streptomyces phaechromogenes
NRRL1248

99

JQ422177

E9

Streptomyces durmitorensis

99

JQ422178

E25

Streptomyces sp. 82293

99

JQ422179

SK119

Erwinia sp.

99

JQ422180

Unknown 9

Not sequenced

N/A

N/A

used).
Regardless, the metabolites produced by
the cave actinomycete strains in this preliminary
study appear to be fairly effective antimicrobial and
antifungal agents against Mycobacterium smegmatis
(which is a model organism for the tuberculosis drug
search) and Candida albicans in particular, and may
have valuable clinical applications in the future.
The percentage of cave actinomycete strains that
produced antimicrobials against the pathogens in
our project is comparable to the percentage of cave
Streptomyces strains that produced antimicrobials
against the pathogens in another recent study (Yücel &
Yamaç, 2010). These authors tested 290 Streptomyces
strains isolated from several caves in Turkey for their
antimicrobial activities against MRSA, VRE, and
Acinetobacter baumannii. They found that 62% or 180
out of 290 strains produced antimicrobial activities
against these pathogens in the primary screening
process, which is similar to the 57% or 100 out of
176 actinomycete strains that produced antimicrobial
activities against the pathogens in our project.
Conversely, the percentage of cave actinomycete
strains that produced antimicrobials against the
pathogens in our project is high compared to a
study conducted by Montano & Henderson in 2012
to determine the effects of nutrient level and human
visitation on the antimicrobial activity of cave bacteria
from three carbonate caves in Carlsbad Caverns
National Park, New Mexico, USA. In this study, 21.1%
of the isolates taken from the Backcountry Cave,
19.8% of the isolates taken from the Spider Cave, and
8.62% of the isolates derived from the Fort Stanton
Cave showed antimicrobial activity against at least one
of the five target bacterial pathogens tested against in
the experiment (Staphylococcus aureus (ATCC 6538),
Klebsiella pneumoniae (ATCC 13883), Proteus vulgaris
(ATCC 13315), Shigella flexneri (ATCC 9199), and
Streptococcus pneumoniae (ATCC 6303), compared to
the 57% of cave actinomycete strains that produced
antimicrobial activity against the pathogens in our
project. On the other hand, a second study conducted
by Montano and Henderson in 2012 to examine the
effects of a lack of nutrients and cave depth on the
antimicrobial activity of cave bacteria from three
carbonate caves in Carlsbad Caverns National Park,
New Mexico, USA, showed more comparable results
to our study. In this study, 66% of the isolates in the
Left Hand Tunnel passage in Carlsbad Caverns, 24%
of the isolates in Spider Cave, 24% of the isolates
in Backcountry Cave, and 40% of the isolates in
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Lechuguilla Cave had antimicrobial activity against at
least one of the five pathogens listed in Montano &
Henderson’s first study above.
Similarly, numerous recent studies have also
isolated novel Streptomyces strains from cave and
desert soils that produced antimicrobial compounds
against a variety of drug-resistant pathogens. For
instance, earlier this year, Rajput and colleagues
discovered seven novel streptomycete strains isolated
from the Kotsumar Cave in India that had varying
antimicrobial activities against Staphylococcus
aureus MTCC 96, Escherichia coli MTCC 1667, and
Pseudomonas aeruginosa JNMC (Rajput et al., 2012).
Likewise, in 2005, Herold and colleagues discovered
that the novel Streptomyces tendae strain HKI 0179
isolated from an ancient cave in Italy Grotta dei Cervi
produced antimicrobial activities against Bacillus
subtilis ATCC 6633, Staphylococcus aureus SG511,
Staphylococcus aureus 134/93, vancomycin-resistant
Enterococcus faecalis 1528 and efflux-resistant
Staphylococcus aureus EfS4 (Herold et al., 2005). As
well, in 2009, Selvameenal and colleagues showed
that the novel Streptomyces hygroscopicus subsp.
ossamyceticus strain D10 isolated from desert soil
in Rajasthan, northwest India produced a range
of antimicrobial activities against Staphylococcus
aureus, vancomycin-resistant Staphylococcus aureus,
extended spectrum β-lactamase (ESBL)-producing
Escherichia coli and Klebsiella sp. (Selvameenal et al.,
2009). Based on the results of these studies and the
results of this project, the future of isolating novel
antimicrobial-producing bacterial strains from lessexplored habitats such as caves is promisingly bright.
The effects of UV light on the antimicrobial
activities of cave actinomycete metabolites in our
study are preliminary and must continue to be
investigated in the future. Previous studies have
shown that some plant metabolites are able to be
photoactivated against a number of pathogens
with exposure to UV light (Towers et al., 1999;
Cheeptham & Towers, 2002; Hudson et al., 2002).
In addition, a study carried out by Matias et al.
in 2010 identified several Brazilian medical plant
extracts whose antimicrobial activities against
Staphylococcus aureus were enhanced when the
extracts were exposed to two hours of UV light (5
W/m2, 320-400 nm from four Sylvania F20T12-BLB
lamps, maximum emission at 350 nm- Matias et al.,
2010). Similarly, in 2002, Rajakaruna and colleagues
tested the antimicrobial activities of the extracts
of 32 species of Sri Lankan plants against seven
pathogens (MRSA, Bacillus subtilis, Enterobacter
faecalis, Escherichia coli, Pseudomonas aeruginosa
H187 (wild type), Mycobacterium phlei, and Candida
albicans) when the extracts were subjected to
45 minutes of long wave UV light (Sylvania,
F20T12/BLB, 20W, four bulbs – Rajakaruna et
al., 2002). Ten extracts showed light-activated
antimicrobial activities against six of the pathogens.
Antimicrobial activity was enhanced with UV light
exposure against Staphylococcus aureus, Bacillus
subtilis, and Pseudomonas aeruginosa. However,
the antimicrobial activity levels of the extracts
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remained the same for Enterobacter faecalis and
Mycobacterium phlei when the extracts were exposed
to UV light and no light conditions and no extract
had light-mediated antimicrobial activities against
Escherichia coli. Conversely, to our knowledge, no
previous study has looked at the effects of UV light
on the deactivation/activation of the antimicrobial
activities of bacterial metabolites from cave
actinomycetes. Photoactivation of metabolites by
UV light may act as a novel source of drug discovery
and more specifically, narrow spectrum antibiotics.
Future work should also examine the effects of
UV light exposure on the cave actinomycete strains
and pathogens that were used in this project. These
microorganisms were also exposed to UV light
during our project which may have had significant
implications on the results obtained from our study.
Short wave UV light exposure is known to cause
extensive damage and mutations to arise in bacterial
DNA (Snider et al., 2009). It triggers the formation
of pyrimidine dimers that alter the structures of
the nucleic acids and prevents DNA polymerase
from replicating bacterial DNA (Farrell et al.,
2009). However, some bacteria possess DNA repair
mechanisms such as excision repair, post replication
repair (Snider et al., 2009), SOS-repair (Chapple et
al., 1992), and photoreactivation (Sayed 2011), which
allow them to repair DNA damage caused by UV
radiation exposure.
A study carried out by Farrell and colleagues in 2009
looked at the effects of pulsed light rich in UV-C waves
(200-280 nm) on the inactivation of clinical pathogens
such as Staphylococcus aureus, Enterococcus faecium,
Acinetobacter baumannii, Escherichia coli and
Pseudomonas aeruginosa (Farrell et al., 2009). One
pulse per second of pulsed light was administered
and the amount of light pulses given varied from
0 to 60. The distance of the light source from the
pathogens ranged from 8-20 cm. Overall, the levels of
each of the pathogens were reduced by approximately
7 log10 CFU cm-2 with exposure to the pulsed light.
Greater inactivation occurred as the intensity of the
light source and the number of pulses increased, and
as the distance of the pathogen plates from the light
source decreased. Thus, it is possible that the levels of
the pathogens used in our project may have decreased
with UV light exposure as described by these studies.
Future aspects for our next study should explore
this possibility, along with the effects of different UV
exposure times on the pathogens used in the current
study, as all plates were previously exposed to one
hour of UV light.
Similarly, the response of cave bacteria to UV light
was previously measured in a study conducted by
Northup et al. (2004). In this study, bacterial cultures
from Four Windows Cave, a lava tube in New Mexico,
USA, were tested for their sensitivity to a 100 and 50
second dosage of UV light. All of the strains tested
showed varying sensitivity to the 100 second dose of
UV light, while all but four strains were sensitive to
the 50 second dose of UV light. The bacterial strains
taken from inside the cave were also more sensitive
to UV light than the bacterial strains taken from the
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surface of the cave. These results suggest that cave
bacteria lose their resistance to UV light as part of an
evolutionary adaptation to living in a dark environment.
Accordingly, Snider et al. (2009) conducted a study
demonstrating that bacteria from Left Hand Tunnel
in Carlsbad Caverns, New Mexico, USA had a reduced
ability to survive damage caused by UV light exposure.
However, actinomycetes from the Left Hand Tunnel
of the Carlsbad Caverns experience a great deal of
human interaction, making these bacteria less like
true cave-adapted strains. Regardless, it is possible
that exposing cave microorganisms that traditionally
live in the dark to new, lighted environments
may stimulate the antimicrobial activities of their
metabolites without having any serious consequences
on their cells. However, given the results of these
studies, future work must examine the effects of UV
light on the cave actinomycetes used in our study.
It is possible that this study may also be improved
by slightly modifying the way that the plug assay is
carried out. For example, shortening the UV exposure
time and exposing the cave actinomycete HT agar
plates to UV light before taking plugs of the strains
may prevent the pathogens from being exposed to
UV light and from potentially influencing the results
of the assay. Additionally, culturing each of the
cave actinomycete isolates in fermentation broth,
transferring the metabolites in the broth onto sterile
paper disks, and exposing these impregnated paper
disks separately to UV may help us better understand
the effects of UV exposure on the metabolites. Overall,
however, our study serves as an important pilot study
for future work regarding the effects of UV light on
the antimicrobial activities of cave actinomycete
metabolites. It is vital that future studies continue
to
search
for
novel
antimicrobial-producing
actinomycete strains in less-explored habitats like
caves and continue to test the effects of UV light
on the antimicrobial activities of cave actinomycete
metabolites in order to help combat the ever-increasing
phenomenon of antimicrobial resistance.
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